Literature DB >> 11159968

Comparison of the hydrophobic properties of Candida albicans and Candida dubliniensis.

K C Hazen1, J G Wu, J Masuoka.   

Abstract

Although Candida dubliniensis is a close genetic relative of Candida albicans, it colonizes and infects fewer sites. Nearly all instances of candidiasis caused by C. dubliniensis are restricted to the oral cavity. As cell surface hydrophobicity (CSH) influences virulence of C. albicans, CSH properties of C. dubliniensis were investigated and compared to C. albicans. Growth temperature is one factor which affects the CSH status of stationary-phase C. albicans. However, C. dubliniensis, similar to other pathogenic non-albicans species of Candida, was hydrophobic regardless of growth temperature. For all Candida species tested in this study (C. albicans, C. dubliniensis, C. glabrata, C. krusei, C. parapsilosis, and C. tropicalis), CSH status correlated with coaggregation with the anaerobic oral bacterium Fusobacterium nucleatum. Previous studies have shown that CSH status of C. albicans involves multiple surface proteins and surface protein N-glycans. The hydrophobic surface glycoprotein CAgp38 appears to be expressed by C. albicans constitutively regardless of growth temperature and medium. C. dubliniensis expresses a 38-kDa protein that cross-reacts with the anti-CAgp38 monoclonal antibody; however, expression of the protein was growth medium and growth temperature dependent. The anti-CAgp38 monoclonal antibody has been shown to inhibit adhesion of C. albicans to extracellular matrix proteins and to vascular endothelial cells. Since protein glycosylation influences the CSH status of C. albicans, we compared the cell wall mannoprotein content and composition between C. albicans and C. dubliniensis. Similar bulk compositional levels of hexose, phosphate, and protein in their N-glycans were determined. However, a component of the C. albicans N-glycan, acid-labile phosphooligomannoside, is expressed much less or negligibly by C. dubliniensis, and when present, the oligomannosides are predominantly less than five mannose residues in length. In addition, the acid-labile phosphooligomannoside profiles varied among the three strains of C. dubliniensis we tested, indicating the N-glycan of C. dubliniensis differs from C. albicans. For C. albicans, the acid-labile phosphooligomannoside influences virulence and surface fibrillar conformation, which affects exposure of hydrophobic surface proteins. Given the combined role in C. albicans of expression of specific surface hydrophobic proteins in pathogenesis and of surface protein glycosylation on exposure of the proteins, the lack of these virulence-associated CSH entities in C. dubliniensis could contribute to its limited ability to cause disseminated infections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159968      PMCID: PMC97952          DOI: 10.1128/IAI.69.2.779-786.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  Beta-1,2-linked oligomannosides inhibit Candida albicans binding to murine macrophage.

Authors:  C Fradin; T Jouault; A Mallet; J M Mallet; D Camus; P Sinaÿ; D Poulain
Journal:  J Leukoc Biol       Date:  1996-07       Impact factor: 4.962

2.  The use of polyacrylamide-gel electrophoresis for the high-resolution separation of reducing saccharides labelled with the fluorophore 8-aminonaphthalene-1,3,6-trisulphonic acid. Detection of picomolar quantities by an imaging system based on a cooled charge-coupled device.

Authors:  P Jackson
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

3.  Prevalence of Candida dubliniensis isolates in a yeast stock collection.

Authors:  F C Odds; L Van Nuffel; G Dams
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients.

Authors:  D M Brown; M A Jabra-Rizk; W A Falkler; A A Baqui; T F Meiller
Journal:  Pediatr Dent       Date:  2000 May-Jun       Impact factor: 1.874

5.  A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.

Authors:  Y Han; R P Morrison; J E Cutler
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

6.  Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients.

Authors:  D Sullivan; D Bennett; M Henman; P Harwood; S Flint; F Mulcahy; D Shanley; D Coleman
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

7.  Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissues.

Authors:  K C Hazen; D L Brawner; M H Riesselman; M A Jutila; J E Cutler
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

8.  Expression of surface hydrophobic proteins by Candida albicans in vivo.

Authors:  P M Glee; P Sundstrom; K C Hazen
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  Detection of beta-1,2-mannosyltransferase in Candida albicans cells.

Authors:  A Suzuki; Y Takata; A Oshie; A Tezuka; N Shibata; H Kobayashi; Y Okawa; S Suzuki
Journal:  FEBS Lett       Date:  1995-10-16       Impact factor: 4.124

10.  Participation of yeast cell surface hydrophobicity in adherence of Candida albicans to human epithelial cells.

Authors:  K C Hazen
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

View more
  10 in total

1.  Susceptibility of Candida species to photodynamic effects of photofrin.

Authors:  Joseph M Bliss; Chad E Bigelow; Thomas H Foster; Constantine G Haidaris
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

2.  Cloning and analysis of a Candida albicans gene that affects cell surface hydrophobicity.

Authors:  D R Singleton; J Masuoka; K C Hazen
Journal:  J Bacteriol       Date:  2001-06       Impact factor: 3.490

3.  Biofilm formation by Candida dubliniensis.

Authors:  G Ramage; K Vande Walle; B L Wickes; J L López-Ribot
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

4.  Cohort Study of Airway Mycobiome in Adult Cystic Fibrosis Patients: Differences in Community Structure between Fungi and Bacteria Reveal Predominance of Transient Fungal Elements.

Authors:  Rolf Kramer; Annette Sauer-Heilborn; Tobias Welte; Carlos A Guzman; Wolf-Rainer Abraham; Manfred G Höfle
Journal:  J Clin Microbiol       Date:  2015-07-01       Impact factor: 5.948

5.  Importance of α- and β/α-linked mannooligosaccharides in antibody response against C. dubliniensis.

Authors:  Izabela Medovarská; Slavomír Bystrický; Zuzana Kossaczká; Eva Machová
Journal:  Glycoconj J       Date:  2010-11-26       Impact factor: 2.916

6.  Cell wall mannan and cell surface hydrophobicity in Candida albicans serotype A and B strains.

Authors:  James Masuoka; Kevin C Hazen
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  Select Streptococci Can Degrade Candida Mannan To Facilitate Growth.

Authors:  Robert Fultz; Taylor Ticer; Janiece Glover; Leah Stripe; Melinda A Engevik
Journal:  Appl Environ Microbiol       Date:  2021-12-22       Impact factor: 5.005

8.  Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.

Authors:  Marcos Martinez; José L López-Ribot; William R Kirkpatrick; Brent J Coco; Stefano P Bachmann; Thomas F Patterson
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  The lipopeptides pseudofactin II and surfactin effectively decrease Candida albicans adhesion and hydrophobicity.

Authors:  Piotr Biniarz; Gabriela Baranowska; Joanna Feder-Kubis; Anna Krasowska
Journal:  Antonie Van Leeuwenhoek       Date:  2015-05-29       Impact factor: 2.271

10.  Biofilm eradication and antifungal mechanism of action against Candida albicans of cationic dicephalic surfactants with a labile linker.

Authors:  Emil Paluch; Jakub Szperlik; Łukasz Lamch; Kazimiera A Wilk; Ewa Obłąk
Journal:  Sci Rep       Date:  2021-04-26       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.